Skip to content

SKILL.md

Latest commit

 

History

History
224 lines (165 loc) · 7.46 KB

SKILL.md

File metadata and controls

224 lines (165 loc) · 7.46 KB

name: 'molecular-glue-discovery-agent' description: 'AI-powered molecular glue discovery for targeted protein degradation, enabling neo-substrate recruitment and undruggable target degradation through E3 ligase interface modulation.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:

  • read_file
  • run_shell_command

Molecular Glue Discovery Agent

The Molecular Glue Discovery Agent enables AI-driven discovery of molecular glue degraders that induce protein-protein interactions between E3 ligases and neo-substrates for targeted protein degradation. Unlike PROTACs, molecular glues are smaller, more drug-like molecules that can access previously "undruggable" targets through induced proximity mechanisms.

When to Use This Skill

  • When discovering new molecular glue scaffolds.
  • For identifying neo-substrate targets for existing glues.
  • To design glues for specific E3-substrate pairs.
  • When optimizing glue selectivity and potency.
  • For virtual screening of glue candidates.

Core Capabilities

  1. Glue Scaffold Discovery: Identify novel molecular glue chemotypes.

  2. Neo-Substrate Prediction: Predict proteins degraded by glues.

  3. Interface Modeling: Model E3-glue-substrate ternary interfaces.

  4. Selectivity Optimization: Design for specific substrate profiles.

  5. SAR Analysis: Structure-activity relationship modeling.

  6. Virtual Screening: Screen compounds for glue activity.

Molecular Glue Mechanisms

Class E3 Ligase Mechanism Example
IMiDs CRBN Degron recognition Lenalidomide
CELMoDs CRBN Enhanced IKZF binding Iberdomide
DCAF15 Glues DCAF15 Splicing factor degradation Indisulam
CDK12 Glues DDB1-CRBN Cyclin K degradation CR8 derivatives
β-catenin Glues Novel WNT pathway targets Emerging

Key Neo-Substrates

Substrate Glue Class Disease Relevance
IKZF1/3 IMiDs Multiple myeloma
CK1α Lenalidomide MDS del(5q)
GSPT1 CC-885 AML
RBM39 Indisulam Solid tumors
Cyclin K CR8 Cancer
SALL4 Thalidomide Teratogenicity

Workflow

  1. Input: Target substrate, E3 ligase, screening library.

  2. Interface Analysis: Model E3 surface and potential binding sites.

  3. Virtual Screening: Screen compounds for interface binding.

  4. Glue Scoring: Predict neo-substrate recruitment potential.

  5. Selectivity Analysis: Predict off-target degradation.

  6. Optimization: Iterative design for potency/selectivity.

  7. Output: Ranked glue candidates with predicted profiles.

Example Usage

User: "Discover molecular glues that degrade IKZF1 through CRBN with improved selectivity over IKZF3."

Agent Action:

python3 Skills/Drug_Discovery/Molecular_Glue_Discovery_Agent/discover_glue.py \
    --target_substrate IKZF1 \
    --e3_ligase CRBN \
    --selectivity_against IKZF3 \
    --scaffold_library imid_derivatives.sdf \
    --interface_model crbn_ikzf1_complex.pdb \
    --n_candidates 100 \
    --output glue_discovery/

Glue Design Parameters

Parameter Consideration Optimization
Interface Complementarity E3-substrate fit Shape/electrostatics
Degron Recognition Substrate degron motifs Motif compatibility
Binding Cooperativity Positive cooperativity Enhanced ternary
Selectivity Off-target degradation Substrate specificity
Drug Properties MW, solubility, permeability Standard optimization

Output Components

Output Description Format
Glue Candidates Ranked molecules .sdf, SMILES
Predicted Substrates Neo-substrate profiles .csv
Interface Models Ternary complex structures .pdb
Selectivity Scores On-target vs off-target .csv
Degradation Predictions DC50, Dmax estimates .csv
SAR Analysis Structure-activity trends .json

AI/ML Components

Interface Prediction:

  • Protein-protein docking
  • Molecular surface analysis
  • Deep learning interface scoring

Neo-Substrate Discovery:

  • Degron motif prediction
  • Proteome-wide screening
  • Structural similarity to known substrates

Glue Optimization:

  • Generative chemistry
  • Multi-objective optimization
  • Active learning for synthesis prioritization

Glue vs PROTAC Comparison

Feature Molecular Glue PROTAC
Molecular Weight <500 Da 700-1500 Da
Target Discovery Serendipitous/AI Rational
Selectivity Can be exquisite Often broader
Substrate Range Induced neo-substrates Direct binders
Oral Bioavailability Generally better Challenging

Clinical Pipeline (2026)

Drug Mechanism Target Phase
Iberdomide (CC-220) CELMoD IKZF1/3, Aiolos Phase 3
Mezigdomide (CC-92480) CELMoD IKZF1/3 Phase 3
Golcadomide (CC-99282) CELMoD IKZF1/3 Phase 2
CFT7455 IKZF1/3 IKZF1/3 Phase 1

Degron Motif Analysis

Degron Type Sequence Features E3 Recognition
Zinc Finger C2H2 ZF domain CRBN-IMiD
Phosphodegron pSer/pThr motifs SCF E3s
N-degron N-terminal residues UBR1/2
Hydrophobic Exposed hydrophobics Quality control

Prerequisites

  • Python 3.10+
  • RDKit, Molecular modeling tools
  • AlphaFold2/3, docking software
  • Deep learning frameworks
  • Protein structure databases

Related Skills

  • PROTAC_Design_Agent - Bifunctional degraders
  • TPD_Ternary_Complex_Agent - Complex modeling
  • Virtual_Screening_Agent - High-throughput screening
  • Protein_Protein_Docking_Agent - PPI modeling

Discovery Strategies

Strategy Approach Success Examples
Phenotypic Screening Degradation readout IMiDs, indisulam
Target-Based E3-substrate docking Rational glues
Chemoproteomics Pull-down identification Neo-substrate discovery
AI-Guided Computational prediction Emerging

Special Considerations

  1. Polypharmacology: Glues often degrade multiple substrates
  2. Species Differences: Neo-substrates may differ across species
  3. Resistance: Substrate mutations, E3 downregulation
  4. Toxicity: Off-target degradation (e.g., SALL4)
  5. Hook Effect: Less common than PROTACs

Quality Control

Metric Purpose Threshold
Interface Score Complex stability >0.6
Cooperativity Enhanced binding >1.5
Selectivity Index On/off-target ratio >10
Drug-likeness Developability Lipinski compliant

Future Directions

Direction Status Potential
New E3 Ligases Active research Expanded target space
Protein-Protein Glues Emerging Beyond degradation
AI-First Discovery Advancing Reduced serendipity
Combination Glues Conceptual Multi-target degradation

Author

AI Group - Biomedical AI Platform